1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chronic Heart Failure Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 ICDs 1.2.3 VADs 1.2.4 Drugs 1.2.5 Others 1.3 Market by Application 1.3.1 Global Chronic Heart Failure Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Household 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Chronic Heart Failure Treatment Market Perspective (2017-2028) 2.2 Chronic Heart Failure Treatment Growth Trends by Region 2.2.1 Chronic Heart Failure Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Chronic Heart Failure Treatment Historic Market Size by Region (2017-2022) 2.2.3 Chronic Heart Failure Treatment Forecasted Market Size by Region (2023-2028) 2.3 Chronic Heart Failure Treatment Market Dynamics 2.3.1 Chronic Heart Failure Treatment Industry Trends 2.3.2 Chronic Heart Failure Treatment Market Drivers 2.3.3 Chronic Heart Failure Treatment Market Challenges 2.3.4 Chronic Heart Failure Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chronic Heart Failure Treatment Players by Revenue 3.1.1 Global Top Chronic Heart Failure Treatment Players by Revenue (2017-2022) 3.1.2 Global Chronic Heart Failure Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Chronic Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Chronic Heart Failure Treatment Revenue 3.4 Global Chronic Heart Failure Treatment Market Concentration Ratio 3.4.1 Global Chronic Heart Failure Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chronic Heart Failure Treatment Revenue in 2021 3.5 Chronic Heart Failure Treatment Key Players Head office and Area Served 3.6 Key Players Chronic Heart Failure Treatment Product Solution and Service 3.7 Date of Enter into Chronic Heart Failure Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chronic Heart Failure Treatment Breakdown Data by Type 4.1 Global Chronic Heart Failure Treatment Historic Market Size by Type (2017-2022) 4.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2023-2028) 5 Chronic Heart Failure Treatment Breakdown Data by Application 5.1 Global Chronic Heart Failure Treatment Historic Market Size by Application (2017-2022) 5.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Chronic Heart Failure Treatment Market Size (2017-2028) 6.2 North America Chronic Heart Failure Treatment Market Size by Country (2017-2022) 6.3 North America Chronic Heart Failure Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Chronic Heart Failure Treatment Market Size (2017-2028) 7.2 Europe Chronic Heart Failure Treatment Market Size by Country (2017-2022) 7.3 Europe Chronic Heart Failure Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Chronic Heart Failure Treatment Market Size (2017-2028) 8.2 Asia-Pacific Chronic Heart Failure Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Chronic Heart Failure Treatment Market Size (2017-2028) 9.2 Latin America Chronic Heart Failure Treatment Market Size by Country (2017-2022) 9.3 Latin America Chronic Heart Failure Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chronic Heart Failure Treatment Market Size (2017-2028) 10.2 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Medtronic 11.1.1 Medtronic Company Detail 11.1.2 Medtronic Business Overview 11.1.3 Medtronic Chronic Heart Failure Treatment Introduction 11.1.4 Medtronic Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.1.5 Medtronic Recent Development 11.2 Abbott 11.2.1 Abbott Company Detail 11.2.2 Abbott Business Overview 11.2.3 Abbott Chronic Heart Failure Treatment Introduction 11.2.4 Abbott Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.2.5 Abbott Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Detail 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Chronic Heart Failure Treatment Introduction 11.3.4 Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.3.5 Johnson & Johnson Recent Development 11.4 Merck 11.4.1 Merck Company Detail 11.4.2 Merck Business Overview 11.4.3 Merck Chronic Heart Failure Treatment Introduction 11.4.4 Merck Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.4.5 Merck Recent Development 11.5 Stanley Pharmaceuticals 11.5.1 Stanley Pharmaceuticals Company Detail 11.5.2 Stanley Pharmaceuticals Business Overview 11.5.3 Stanley Pharmaceuticals Chronic Heart Failure Treatment Introduction 11.5.4 Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.5.5 Stanley Pharmaceuticals Recent Development 11.6 New Haven Pharmaceuticals, Inc. 11.6.1 New Haven Pharmaceuticals, Inc. Company Detail 11.6.2 New Haven Pharmaceuticals, Inc. Business Overview 11.6.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Introduction 11.6.4 New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.6.5 New Haven Pharmaceuticals, Inc. Recent Development 11.7 Boston Scientific Corporation 11.7.1 Boston Scientific Corporation Company Detail 11.7.2 Boston Scientific Corporation Business Overview 11.7.3 Boston Scientific Corporation Chronic Heart Failure Treatment Introduction 11.7.4 Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.7.5 Boston Scientific Corporation Recent Development 11.8 HeartWare 11.8.1 HeartWare Company Detail 11.8.2 HeartWare Business Overview 11.8.3 HeartWare Chronic Heart Failure Treatment Introduction 11.8.4 HeartWare Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.8.5 HeartWare Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Detail 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Chronic Heart Failure Treatment Introduction 11.9.4 Pfizer Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.9.5 Pfizer Recent Development 11.10 GlaxoSmithKline plc 11.10.1 GlaxoSmithKline plc Company Detail 11.10.2 GlaxoSmithKline plc Business Overview 11.10.3 GlaxoSmithKline plc Chronic Heart Failure Treatment Introduction 11.10.4 GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.10.5 GlaxoSmithKline plc Recent Development 11.11 Novartis International AG 11.11.1 Novartis International AG Company Detail 11.11.2 Novartis International AG Business Overview 11.11.3 Novartis International AG Chronic Heart Failure Treatment Introduction 11.11.4 Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.11.5 Novartis International AG Recent Development 11.12 Biovail Corporation 11.12.1 Biovail Corporation Company Detail 11.12.2 Biovail Corporation Business Overview 11.12.3 Biovail Corporation Chronic Heart Failure Treatment Introduction 11.12.4 Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.12.5 Biovail Corporation Recent Development 11.13 Bristol-Myers Squibb Company 11.13.1 Bristol-Myers Squibb Company Company Detail 11.13.2 Bristol-Myers Squibb Company Business Overview 11.13.3 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Introduction 11.13.4 Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.13.5 Bristol-Myers Squibb Company Recent Development 11.14 Abiomed 11.14.1 Abiomed Company Detail 11.14.2 Abiomed Business Overview 11.14.3 Abiomed Chronic Heart Failure Treatment Introduction 11.14.4 Abiomed Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.14.5 Abiomed Recent Development 11.15 Symplmed Pharmaceuticals 11.15.1 Symplmed Pharmaceuticals Company Detail 11.15.2 Symplmed Pharmaceuticals Business Overview 11.15.3 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Introduction 11.15.4 Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.15.5 Symplmed Pharmaceuticals Recent Development 11.16 Berlin Heart GmbH 11.16.1 Berlin Heart GmbH Company Detail 11.16.2 Berlin Heart GmbH Business Overview 11.16.3 Berlin Heart GmbH Chronic Heart Failure Treatment Introduction 11.16.4 Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.16.5 Berlin Heart GmbH Recent Development 11.17 ReliantHeart, Inc. 11.17.1 ReliantHeart, Inc. Company Detail 11.17.2 ReliantHeart, Inc. Business Overview 11.17.3 ReliantHeart, Inc. Chronic Heart Failure Treatment Introduction 11.17.4 ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.17.5 ReliantHeart, Inc. Recent Development 11.18 Cardiokinetix 11.18.1 Cardiokinetix Company Detail 11.18.2 Cardiokinetix Business Overview 11.18.3 Cardiokinetix Chronic Heart Failure Treatment Introduction 11.18.4 Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.18.5 Cardiokinetix Recent Development 11.19 Biotronik 11.19.1 Biotronik Company Detail 11.19.2 Biotronik Business Overview 11.19.3 Biotronik Chronic Heart Failure Treatment Introduction 11.19.4 Biotronik Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.19.5 Biotronik Recent Development 11.20 Jarvik Heart 11.20.1 Jarvik Heart Company Detail 11.20.2 Jarvik Heart Business Overview 11.20.3 Jarvik Heart Chronic Heart Failure Treatment Introduction 11.20.4 Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2017-2022) 11.20.5 Jarvik Heart Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Chronic Heart Failure Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of ICDs Table 3. Key Players of VADs Table 4. Key Players of Drugs Table 5. Key Players of Others Table 6. Global Chronic Heart Failure Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Chronic Heart Failure Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Chronic Heart Failure Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Chronic Heart Failure Treatment Market Share by Region (2017-2022) Table 10. Global Chronic Heart Failure Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Chronic Heart Failure Treatment Market Share by Region (2023-2028) Table 12. Chronic Heart Failure Treatment Market Trends Table 13. Chronic Heart Failure Treatment Market Drivers Table 14. Chronic Heart Failure Treatment Market Challenges Table 15. Chronic Heart Failure Treatment Market Restraints Table 16. Global Chronic Heart Failure Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Chronic Heart Failure Treatment Market Share by Players (2017-2022) Table 18. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2021) Table 19. Ranking of Global Top Chronic Heart Failure Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Chronic Heart Failure Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Chronic Heart Failure Treatment Product Solution and Service Table 23. Date of Enter into Chronic Heart Failure Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Chronic Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Chronic Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2017-2022) Table 31. Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2023-2028) Table 33. North America Chronic Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Chronic Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Chronic Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Chronic Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Chronic Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Chronic Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Medtronic Company Detail Table 44. Medtronic Business Overview Table 45. Medtronic Chronic Heart Failure Treatment Product Table 46. Medtronic Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 47. Medtronic Recent Development Table 48. Abbott Company Detail Table 49. Abbott Business Overview Table 50. Abbott Chronic Heart Failure Treatment Product Table 51. Abbott Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 52. Abbott Recent Development Table 53. Johnson & Johnson Company Detail Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Chronic Heart Failure Treatment Product Table 56. Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 57. Johnson & Johnson Recent Development Table 58. Merck Company Detail Table 59. Merck Business Overview Table 60. Merck Chronic Heart Failure Treatment Product Table 61. Merck Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 62. Merck Recent Development Table 63. Stanley Pharmaceuticals Company Detail Table 64. Stanley Pharmaceuticals Business Overview Table 65. Stanley Pharmaceuticals Chronic Heart Failure Treatment Product Table 66. Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 67. Stanley Pharmaceuticals Recent Development Table 68. New Haven Pharmaceuticals, Inc. Company Detail Table 69. New Haven Pharmaceuticals, Inc. Business Overview Table 70. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product Table 71. New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 72. New Haven Pharmaceuticals, Inc. Recent Development Table 73. Boston Scientific Corporation Company Detail Table 74. Boston Scientific Corporation Business Overview Table 75. Boston Scientific Corporation Chronic Heart Failure Treatment Product Table 76. Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 77. Boston Scientific Corporation Recent Development Table 78. HeartWare Company Detail Table 79. HeartWare Business Overview Table 80. HeartWare Chronic Heart Failure Treatment Product Table 81. HeartWare Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 82. HeartWare Recent Development Table 83. Pfizer Company Detail Table 84. Pfizer Business Overview Table 85. Pfizer Chronic Heart Failure Treatment Product Table 86. Pfizer Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 87. Pfizer Recent Development Table 88. GlaxoSmithKline plc Company Detail Table 89. GlaxoSmithKline plc Business Overview Table 90. GlaxoSmithKline plc Chronic Heart Failure Treatment Product Table 91. GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 92. GlaxoSmithKline plc Recent Development Table 93. Novartis International AG Company Detail Table 94. Novartis International AG Business Overview Table 95. Novartis International AG Chronic Heart Failure TreatmentProduct Table 96. Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 97. Novartis International AG Recent Development Table 98. Biovail Corporation Company Detail Table 99. Biovail Corporation Business Overview Table 100. Biovail Corporation Chronic Heart Failure TreatmentProduct Table 101. Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 102. Biovail Corporation Recent Development Table 103. Bristol-Myers Squibb Company Company Detail Table 104. Bristol-Myers Squibb Company Business Overview Table 105. Bristol-Myers Squibb Company Chronic Heart Failure TreatmentProduct Table 106. Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 107. Bristol-Myers Squibb Company Recent Development Table 108. Abiomed Company Detail Table 109. Abiomed Business Overview Table 110. Abiomed Chronic Heart Failure TreatmentProduct Table 111. Abiomed Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 112. Abiomed Recent Development Table 113. Symplmed Pharmaceuticals Company Detail Table 114. Symplmed Pharmaceuticals Business Overview Table 115. Symplmed Pharmaceuticals Chronic Heart Failure TreatmentProduct Table 116. Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 117. Symplmed Pharmaceuticals Recent Development Table 118. Berlin Heart GmbH Company Detail Table 119. Berlin Heart GmbH Business Overview Table 120. Berlin Heart GmbH Chronic Heart Failure TreatmentProduct Table 121. Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 122. Berlin Heart GmbH Recent Development Table 123. ReliantHeart, Inc. Company Detail Table 124. ReliantHeart, Inc. Business Overview Table 125. ReliantHeart, Inc. Chronic Heart Failure TreatmentProduct Table 126. ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 127. ReliantHeart, Inc. Recent Development Table 128. Cardiokinetix Company Detail Table 129. Cardiokinetix Business Overview Table 130. Cardiokinetix Chronic Heart Failure TreatmentProduct Table 131. Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 132. Cardiokinetix Recent Development Table 133. Biotronik Company Detail Table 134. Biotronik Business Overview Table 135. Biotronik Chronic Heart Failure TreatmentProduct Table 136. Biotronik Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 137. Biotronik Recent Development Table 138. Jarvik Heart Company Detail Table 139. Jarvik Heart Business Overview Table 140. Jarvik Heart Chronic Heart Failure TreatmentProduct Table 141. Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 142. Jarvik Heart Recent Development Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Global Chronic Heart Failure Treatment Market Share by Type: 2021 VS 2028 Figure 2. ICDs Features Figure 3. VADs Features Figure 4. Drugs Features Figure 5. Others Features Figure 6. Global Chronic Heart Failure Treatment Market Share by Application in 2021 & 2028 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Household Case Studies Figure 10. Others Case Studies Figure 11. Chronic Heart Failure Treatment Report Years Considered Figure 12. Global Chronic Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Chronic Heart Failure Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Chronic Heart Failure Treatment Market Share by Region: 2021 VS 2028 Figure 15. Global Chronic Heart Failure Treatment Market Share by Players in 2021 Figure 16. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Chronic Heart Failure Treatment Revenue in 2021 Figure 18. North America Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Chronic Heart Failure Treatment Market Share by Country (2017-2028) Figure 20. United States Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Chronic Heart Failure Treatment Market Share by Country (2017-2028) Figure 24. Germany Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Chronic Heart Failure Treatment Market Share by Region (2017-2028) Figure 32. China Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Chronic Heart Failure Treatment Market Share by Country (2017-2028) Figure 40. Mexico Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Chronic Heart Failure Treatment Market Share by Country (2017-2028) Figure 44. Turkey Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Chronic Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Medtronic Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 47. Abbott Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 48. Johnson & Johnson Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 49. Merck Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 50. Stanley Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 51. New Haven Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 52. Boston Scientific Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 53. HeartWare Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 55. GlaxoSmithKline plc Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 56. Novartis International AG Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 57. Biovail Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 59. Abiomed Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 60. Symplmed Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 61. Berlin Heart GmbH Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 62. ReliantHeart, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 63. Cardiokinetix Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 64. Biotronik Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 65. Jarvik Heart Revenue Growth Rate in Chronic Heart Failure Treatment Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Medtronic Abbott Johnson & Johnson Merck Stanley Pharmaceuticals New Haven Pharmaceuticals, Inc. Boston Scientific Corporation HeartWare Pfizer GlaxoSmithKline plc Novartis International AG Biovail Corporation Bristol-Myers Squibb Company Abiomed Symplmed Pharmaceuticals Berlin Heart GmbH ReliantHeart, Inc. Cardiokinetix Biotronik Jarvik Heart